ONL Therapeutics

Helping patients see the future

Website

ONL Therapeutics is a clinical-stage biopharmaceutical company developing innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.

Domain

Topical Ophthamology

First Partnered

Seed

Current Status

Active

Investors

George Magrath

Leadership

David Esposito, CEO

HQ

Ann Arbor, Michigan

In the News

View all